ReviewNature protocols2026
In situ structure determination of conformationally flexible targets using nextPYP.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Single-particle cryoelectron tomography (SP-CET) is an imaging technique capable of determining the structure of proteins in their cellular environment at high-resolution. nextPYP is a web-based application designed to streamline the SP-CET structure determination process and facilitate the analysis of conformational variability. Here we explain how to use nextPYP-based methods to determine the structure and study the conformational heterogeneity of proteins using SP-CET. We provide a step-by-step guide to convert raw tilt-series into three-dimensional structures, following a workflow that includes movie-frame alignment, tilt-series alignment, contrast transfer function estimation, tomogram reconstruction, particle picking, high-resolution refinement and three-dimensional classification. The advantages of nextPYP are its ease-of-use and effectiveness at extracting high-resolution information, which, combined with its storage and compute efficiency, shortens time-to-structure from months to days. The complete procedure, including interactive data analysis and visualization, is fully integrated within the application, with no need for external software. Starting from raw tilt-series data, users will be able to determine a near-atomic resolution structure of human immunodeficiency virus 1 Gag protein, eight translational states of Escherichia coli 70S ribosomes and a structure of human 80S ribosomes from plasma-focused ion beam milled HeLa cells. This Protocol is intended as a resource for those who are new to SP-CET as well as more experienced users that want to streamline the process of in situ structure determination and heterogeneity analysis using nextPYP. The procedure requires 18 h to complete.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.